US5545553A
(en)
*
|
1994-09-26 |
1996-08-13 |
The Rockefeller University |
Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
|
CA2227013A1
(en)
|
1995-07-14 |
1997-02-06 |
Glycotech Corp. |
Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor
|
US6458574B1
(en)
*
|
1996-09-12 |
2002-10-01 |
Transkaryotic Therapies, Inc. |
Treatment of a α-galactosidase a deficiency
|
US6083725A
(en)
*
|
1996-09-13 |
2000-07-04 |
Transkaryotic Therapies, Inc. |
Tranfected human cells expressing human α-galactosidase A protein
|
JP2001507215A
(ja)
*
|
1997-01-16 |
2001-06-05 |
サイテル コーポレイション |
組換え糖タンパク質のインビトロでの実用的なシアリル化
|
US20040191256A1
(en)
*
|
1997-06-24 |
2004-09-30 |
Genentech, Inc. |
Methods and compositions for galactosylated glycoproteins
|
DE19754622A1
(de)
|
1997-12-09 |
1999-06-10 |
Antje Von Dr Schaewen |
Pflanzliche GntI-Sequenzen und Verwendung derselben zur Gewinnung von Pflanzen mit verminderter oder fehlender N-Acetylglucosaminyltransferase I (GnTI)-Aktivität
|
US7244601B2
(en)
*
|
1997-12-15 |
2007-07-17 |
National Research Council Of Canada |
Fusion proteins for use in enzymatic synthesis of oligosaccharides
|
WO2001025406A1
(en)
*
|
1999-10-01 |
2001-04-12 |
University Of Victoria Innovation & Development Corporation |
Mannosidases and methods for using same
|
EP1278881B1
(de)
|
2000-04-13 |
2009-12-30 |
Biotica Technology Limited |
Glycosylierte hybrid-verbindungen, deren herstellung und verwendung
|
DE60139720D1
(de)
|
2000-06-28 |
2009-10-08 |
Glycofi Inc |
Verfahren für die Herstellung modifizierter Glykoproteine
|
US20060034828A1
(en)
*
|
2000-06-28 |
2006-02-16 |
Gerngross Tillman U |
Immunoglobulins comprising predominantly a GlcNAcMAN5GLCNAC2 glycoform
|
US7598055B2
(en)
*
|
2000-06-28 |
2009-10-06 |
Glycofi, Inc. |
N-acetylglucosaminyltransferase III expression in lower eukaryotes
|
US20060034830A1
(en)
*
|
2000-06-28 |
2006-02-16 |
Gerngross Tillman U |
Immunoglobulins comprising predominantly a GalGlcNAcMan5GLcNAc2 glycoform
|
US7625756B2
(en)
|
2000-06-28 |
2009-12-01 |
GycoFi, Inc. |
Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells
|
US7449308B2
(en)
|
2000-06-28 |
2008-11-11 |
Glycofi, Inc. |
Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
|
US8697394B2
(en)
*
|
2000-06-28 |
2014-04-15 |
Glycofi, Inc. |
Production of modified glycoproteins having multiple antennary structures
|
US20060024304A1
(en)
*
|
2000-06-28 |
2006-02-02 |
Gerngross Tillman U |
Immunoglobulins comprising predominantly a Man5GlcNAc2 glycoform
|
US7863020B2
(en)
|
2000-06-28 |
2011-01-04 |
Glycofi, Inc. |
Production of sialylated N-glycans in lower eukaryotes
|
EP2028275A3
(de)
*
|
2000-06-30 |
2009-05-06 |
VIB vzw |
Modifikation der Proteinglycosylierung in Pichia Pastoris
|
EP1371732B1
(de)
*
|
2001-02-26 |
2008-12-31 |
Toyo Boseki Kabushiki Kaisha |
Fusionsprotein mit beta-1,2-n-acetylglucosaminyl-transferase-ii-aktivität und herstellungsverfahren dafür
|
US7696163B2
(en)
|
2001-10-10 |
2010-04-13 |
Novo Nordisk A/S |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
US8008252B2
(en)
|
2001-10-10 |
2011-08-30 |
Novo Nordisk A/S |
Factor VII: remodeling and glycoconjugation of Factor VII
|
US7125843B2
(en)
*
|
2001-10-19 |
2006-10-24 |
Neose Technologies, Inc. |
Glycoconjugates including more than one peptide
|
US7439043B2
(en)
*
|
2001-10-10 |
2008-10-21 |
Neose Technologies, Inc. |
Galactosyl nucleotide sugars
|
US7157277B2
(en)
*
|
2001-11-28 |
2007-01-02 |
Neose Technologies, Inc. |
Factor VIII remodeling and glycoconjugation of Factor VIII
|
US7297511B2
(en)
*
|
2001-10-10 |
2007-11-20 |
Neose Technologies, Inc. |
Interferon alpha: remodeling and glycoconjugation of interferon alpha
|
US7265084B2
(en)
*
|
2001-10-10 |
2007-09-04 |
Neose Technologies, Inc. |
Glycopegylation methods and proteins/peptides produced by the methods
|
US7265085B2
(en)
*
|
2001-10-10 |
2007-09-04 |
Neose Technologies, Inc. |
Glycoconjugation methods and proteins/peptides produced by the methods
|
US7173003B2
(en)
|
2001-10-10 |
2007-02-06 |
Neose Technologies, Inc. |
Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
|
US7795210B2
(en)
|
2001-10-10 |
2010-09-14 |
Novo Nordisk A/S |
Protein remodeling methods and proteins/peptides produced by the methods
|
US7214660B2
(en)
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
US7399613B2
(en)
*
|
2001-10-10 |
2008-07-15 |
Neose Technologies, Inc. |
Sialic acid nucleotide sugars
|
US7226903B2
(en)
*
|
2001-10-10 |
2007-06-05 |
Neose Technologies, Inc. |
Interferon beta: remodeling and glycoconjugation of interferon beta
|
ES2516041T3
(es)
*
|
2001-10-10 |
2014-10-30 |
Ratiopharm Gmbh |
Remodelación y glicoconjugación de la hormona del crecimiento humano (hGH)
|
US7179617B2
(en)
|
2001-10-10 |
2007-02-20 |
Neose Technologies, Inc. |
Factor IX: remolding and glycoconjugation of Factor IX
|
AU2002340562B2
(en)
*
|
2001-10-22 |
2008-10-23 |
Merck Serono Sa |
Compositions of FSH with high sialylation degree and their use for the preparation of medicaments
|
US20030232383A1
(en)
*
|
2001-11-02 |
2003-12-18 |
Sylvia Daunert |
Novel reagentless sensing system for measuring carbohydrates based on the galactose/glucose binding protein
|
US7473680B2
(en)
*
|
2001-11-28 |
2009-01-06 |
Neose Technologies, Inc. |
Remodeling and glycoconjugation of peptides
|
US20060034829A1
(en)
*
|
2001-12-27 |
2006-02-16 |
Gerngross Tillman U |
Immunoglobulins comprising predominantly a MAN3GLCNAC2 glycoform
|
EP2359685B1
(de)
*
|
2001-12-27 |
2013-12-04 |
GlycoFi, Inc. |
Verfahren für die rekombinante veränderung von kohlenhydratstrukturen des säugetiertyps
|
AU2003210220A1
(en)
*
|
2002-01-23 |
2003-09-02 |
Debiopharm Sa |
Production of epi-hne-4 comprising reduction of improperly processed form
|
EP2361631A1
(de)
*
|
2002-04-25 |
2011-08-31 |
Shire Human Genetic Therapies, Inc. |
Behandlung der alpha-Galactosidase A-Defizienz
|
DE60336555D1
(de)
|
2002-06-21 |
2011-05-12 |
Novo Nordisk Healthcare Ag |
Pegylierte glykoformen von faktor vii
|
IL165717A0
(en)
*
|
2002-06-26 |
2006-01-15 |
Flanders Interuniversity Inst |
A strain of methylotrophic yeast for producing proteins
|
US20060105387A1
(en)
*
|
2002-08-30 |
2006-05-18 |
Prior Christopher P |
Transferrin fusion proteins libraries
|
US7332299B2
(en)
|
2003-02-20 |
2008-02-19 |
Glycofi, Inc. |
Endomannosidases in the modification of glycoproteins in eukaryotes
|
KR20060003862A
(ko)
|
2003-03-14 |
2006-01-11 |
네오스 테크놀로지스, 인크. |
수용성분기폴리머 및 그 접합체
|
MXPA05010773A
(es)
*
|
2003-04-09 |
2005-12-12 |
Neose Technologies Inc |
Metodos de glicopegilacion y proteinas/peptidos producidos por los metodos.
|
US8791070B2
(en)
|
2003-04-09 |
2014-07-29 |
Novo Nordisk A/S |
Glycopegylated factor IX
|
EP1613261A4
(de)
*
|
2003-04-09 |
2011-01-26 |
Novo Nordisk As |
Intrazelluläre bildung von peptidkonjugaten
|
EP1624847B1
(de)
|
2003-05-09 |
2012-01-04 |
BioGeneriX AG |
Zusammensetzungen und Verfahren zur Herstellung von Glykosylierungsmutanten des menschlichen Wachstumshormons
|
WO2005012484A2
(en)
|
2003-07-25 |
2005-02-10 |
Neose Technologies, Inc. |
Antibody-toxin conjugates
|
US7507573B2
(en)
|
2003-11-14 |
2009-03-24 |
Vib, Vzw |
Modification of protein glycosylation in methylotrophic yeast
|
US20080305992A1
(en)
|
2003-11-24 |
2008-12-11 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin
|
AU2004293103C1
(en)
*
|
2003-11-24 |
2010-12-02 |
Ratiopharm Gmbh |
Glycopegylated erythropoietin
|
US7842661B2
(en)
|
2003-11-24 |
2010-11-30 |
Novo Nordisk A/S |
Glycopegylated erythropoietin formulations
|
US8633157B2
(en)
|
2003-11-24 |
2014-01-21 |
Novo Nordisk A/S |
Glycopegylated erythropoietin
|
US7956032B2
(en)
*
|
2003-12-03 |
2011-06-07 |
Novo Nordisk A/S |
Glycopegylated granulocyte colony stimulating factor
|
US20060040856A1
(en)
*
|
2003-12-03 |
2006-02-23 |
Neose Technologies, Inc. |
Glycopegylated factor IX
|
US20080318850A1
(en)
*
|
2003-12-03 |
2008-12-25 |
Neose Technologies, Inc. |
Glycopegylated Factor Ix
|
BRPI0506741A
(pt)
|
2004-01-08 |
2007-05-15 |
Neose Technologies Inc |
glicosilação de peptìdeos ligados a o
|
EP2365089B1
(de)
*
|
2004-03-17 |
2014-05-14 |
GlycoFi, Inc. |
Verfahren zum Bau eines synthetischen Cytidinmonophosphat-Sialsäure-Pfads in Hefe
|
WO2005100584A2
(en)
*
|
2004-04-15 |
2005-10-27 |
Glycofi, Inc. |
Production of galactosylated glycoproteins in lower eukaryotes
|
BRPI0510295A
(pt)
|
2004-05-04 |
2007-11-06 |
Novo Nordisk Healthcare Ag |
preparação de uma glicoproteìna, e, método para produzir a mesma
|
US20080300173A1
(en)
|
2004-07-13 |
2008-12-04 |
Defrees Shawn |
Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1]
|
US8268967B2
(en)
|
2004-09-10 |
2012-09-18 |
Novo Nordisk A/S |
Glycopegylated interferon α
|
EP1797192A1
(de)
*
|
2004-09-29 |
2007-06-20 |
Novo Nordisk Health Care AG |
Modifizierte proteine
|
JP5948627B2
(ja)
|
2004-10-29 |
2016-07-20 |
レイショファーム ゲーエムベーハー |
線維芽細胞成長因子(fgf)のリモデリングと糖質ペグ化
|
EP1858543B1
(de)
|
2005-01-10 |
2013-11-27 |
BioGeneriX AG |
Glycopegylierten Granulocyten-Kolonie-stimulierender Faktor
|
WO2006105426A2
(en)
*
|
2005-03-30 |
2006-10-05 |
Neose Technologies, Inc. |
Manufacturing process for the production of peptides grown in insect cell lines
|
US20070154992A1
(en)
*
|
2005-04-08 |
2007-07-05 |
Neose Technologies, Inc. |
Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
|
JP5216580B2
(ja)
*
|
2005-05-25 |
2013-06-19 |
ノヴォ ノルディスク アー/エス |
グリコペグ化第ix因子
|
US20070105755A1
(en)
|
2005-10-26 |
2007-05-10 |
Neose Technologies, Inc. |
One pot desialylation and glycopegylation of therapeutic peptides
|
JP2009515508A
(ja)
*
|
2005-08-19 |
2009-04-16 |
ネオス テクノロジーズ インコーポレイテッド |
グリコpeg化因子viiおよび因子viia
|
EP1942935A4
(de)
*
|
2005-09-02 |
2009-12-23 |
Glycofi Inc |
Immunglobuline, die vorwiegend eine glcnacman3glcnac2 glycoform enthalten
|
US20090048440A1
(en)
|
2005-11-03 |
2009-02-19 |
Neose Technologies, Inc. |
Nucleotide Sugar Purification Using Membranes
|
CN101516388B
(zh)
*
|
2006-07-21 |
2012-10-31 |
诺和诺德公司 |
通过o-联糖基化序列的肽的糖基化
|
EP2054521A4
(de)
|
2006-10-03 |
2012-12-19 |
Novo Nordisk As |
Verfahren zur reinigung von polypeptid-konjugate
|
WO2008073620A2
(en)
*
|
2006-11-02 |
2008-06-19 |
Neose Technologies, Inc. |
Manufacturing process for the production of polypeptides expressed in insect cell-lines
|
US9862956B2
(en)
|
2006-12-10 |
2018-01-09 |
Danisco Us Inc. |
Expression and high-throughput screening of complex expressed DNA libraries in filamentous fungi
|
EP2102366A4
(de)
|
2006-12-10 |
2010-01-27 |
Dyadic International Inc |
Expression und hochdurchsatz-screening komplexer exprimierter dna-bibliotheken bei fadenpilzen
|
JP5184786B2
(ja)
*
|
2007-01-19 |
2013-04-17 |
サントリーホールディングス株式会社 |
フラボノイド類の配糖化方法
|
RS52845B
(en)
|
2007-04-03 |
2013-12-31 |
Biogenerix Ag |
TREATMENT PROCEDURES USING GLYCOPEGILATED G-CSF
|
CN104480140B
(zh)
|
2007-04-03 |
2019-12-31 |
奥克西雷恩英国有限公司 |
分子的糖基化
|
US20090053167A1
(en)
*
|
2007-05-14 |
2009-02-26 |
Neose Technologies, Inc. |
C-, S- and N-glycosylation of peptides
|
US9493499B2
(en)
|
2007-06-12 |
2016-11-15 |
Novo Nordisk A/S |
Process for the production of purified cytidinemonophosphate-sialic acid-polyalkylene oxide (CMP-SA-PEG) as modified nucleotide sugars via anion exchange chromatography
|
US8207112B2
(en)
|
2007-08-29 |
2012-06-26 |
Biogenerix Ag |
Liquid formulation of G-CSF conjugate
|
EP2257311B1
(de)
|
2008-02-27 |
2014-04-16 |
Novo Nordisk A/S |
Konjugierte faktor-viii-moleküle
|
EP2435476A4
(de)
*
|
2009-05-27 |
2013-04-17 |
Synageva Biopharma Corp |
Aus vögeln gewonnene antikörper
|
CN104651428A
(zh)
|
2009-09-29 |
2015-05-27 |
根特大学 |
水解甘露糖-1-磷酸-6-甘露糖连接为磷酸-6-甘露糖
|
US20120213728A1
(en)
*
|
2009-10-30 |
2012-08-23 |
Merck |
Granulocyte-colony stimulating factor produced in glycoengineered pichia pastoris
|
BR112012011980A2
(pt)
|
2009-11-19 |
2021-09-08 |
Oxyrane Uk Limited |
Métodos de produzir células transformadas de yarrowia lipolytica e proteínas-alvocompreendendo n-glicanos, células transformadas de yarrowia lipolytica e suas culturas, bem como composição compreendendo glicoproteínas
|
CA2799595C
(en)
|
2010-05-27 |
2022-08-16 |
Merck Sharp & Dohme Corp. |
Method for preparing antibodies having improved properties
|
CN103328646B
(zh)
|
2010-09-29 |
2021-06-18 |
奥克西雷恩英国有限公司 |
能够使甘露糖-1-磷酸-6-甘露糖连接脱帽并使磷酸化的n-聚糖脱甘露糖基化的甘露糖苷酶及促进糖蛋白的哺乳动物细胞摄取的方法
|
US9689015B2
(en)
|
2010-09-29 |
2017-06-27 |
Oxyrane Uk Limited |
De-mannosylation of phosphorylated N-glycans
|
CN103582650A
(zh)
|
2011-05-25 |
2014-02-12 |
默沙东公司 |
用于制备具有改善性质的含Fc多肽的方法
|
WO2013087992A1
(en)
*
|
2011-12-13 |
2013-06-20 |
Glykos Finland Oy |
Glycoprotein
|
US9249399B2
(en)
|
2012-03-15 |
2016-02-02 |
Oxyrane Uk Limited |
Methods and materials for treatment of pompe's disease
|
US20160177355A1
(en)
*
|
2013-03-14 |
2016-06-23 |
Adam C. Fisher |
Oligosaccharide compositions, glycoproteins and methods to produce the same in prokaryotes
|
SG11201700446XA
(en)
|
2014-07-21 |
2017-02-27 |
Glykos Finland Oy |
Production of glycoproteins with mammalian-like n-glycans in filamentous fungi
|
WO2019219220A1
(de)
|
2018-05-18 |
2019-11-21 |
Leibniz-Institut für Plasmaforschung und Technologie e.V. |
Desinfektionsverfahren mit einem durch reaktion von h2o2 und no2- in situ gebildetem desinfektionswirkstoff
|